Prognostic factors and staging systems in childhood hepatoblastoma
Open Access
- 6 December 1997
- journal article
- predictive oncology
- Published by Wiley in International Journal of Cancer
- Vol. 74 (6), 593-599
- https://doi.org/10.1002/(sici)1097-0215(19971219)74:6<593::aid-ijc6>3.0.co;2-p
Abstract
The objectives of this study were to investigate clinical and patho-histological characteristics of childhood hepatoblastoma on their value as prognostic factors, and to evaluate the predictive impact of different staging systems for liver tumors on 72 patients treated in the German Pediatric Liver-Tumor Study HB89. Statistical analysis was performed by comparing patients' disease-free survival with characteristics and stages. Multivariate analysis was done by the Cox proportional-hazards model, the recursive partitioning and amalgamation model (RECPAM) and the model of clustering by response (CBR). The following characteristics were significantly related with prognosis: tumor involvement of one vs. both liver lobes, multifocal disseminated vs. unifocal growth pattern in the liver, distant metastases, vascular invasion, fetal vs. embryonal differentiation, and serum α-fetoprotein; patients with values of ≤100 ng/ml or ≥1,000,000 ng/ml had a worse outcome than those with 100 to 1,000,000 ng/ml. Multivariate analysis with the 3 models revealed that tumor-growth pattern, serum α-fetoprotein and, in the Cox and CBR models, vascular invasion also are independent prognostic factors, permitting the allocation of hepatoblastoma patients to 1 of 2 prognostic groups for differential therapy. Post-surgical staging and the conventional TNM system for liver carcinoma had a high predictive value, in contrast to a TNM system proposed by the UICC for testing on childhood liver tumors. We therefore propose that the TNM system for liver carcinoma be applied for comparison of treatment results in hepatoblastoma. Int. J. Cancer 74:593–599, 1997Keywords
This publication has 14 references indexed in Scilit:
- Clustering by response: CBRComputational Statistics & Data Analysis, 1997
- Hepatoblastoma — a bit of a success story?European Journal Of Cancer, 1994
- DNA analysis in hepatoblastoma by flow and image cytometryCancer, 1993
- Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1993
- Hepatoblastoma: The Prognostic Significance of Histologic TypePediatric Pathology, 1992
- Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.Journal of Clinical Oncology, 1991
- Malignant hepatic tumours in children: incidence, clinical features and aetiologyPaediatric and Perinatal Epidemiology, 1990
- Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinomaCancer, 1989
- RECPAM: a computer program for recursive partition and amalgamation for censored survival data and other situations frequently occurring in biostatistics. I. Methods and program featuresComputer Methods and Programs in Biomedicine, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958